• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PULM

PULM

Pulmatrix, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.29

-0.03 (-2.27%)

Rating:C+

Company Profile

CEO

Peter Ludlum

IPO Date

2014-03-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.30

Prev. Close

$1.32

Day Low

$1.29

Day High

$1.37

52W Low

$1.16

52W High

$9.23

Market Cap

$0.00B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

6

Avg Positive

27.5%

Avg Negative

3.7%

Avg Neutral

69.2%

News Feed

PULM Stock: Over 4% Increase Pre-Market Explanation

Pulse2·5/12/2021·↑ positive

Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business Update

PRNewsWire·5/11/2021·↑ positive

Pulmatrix Hosting Key Opinion Webinar on PUR3100 (Orally Inhaled DHE) Therapy for the Treatment of Acute Migraine

PRNewsWire·4/15/2021·↑ positive

Corrected: Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor Portfolio

PRNewsWire·4/12/2021·↓ negative

Pulmatrix Reports 2020 Financial Results and Provides Business Update

PRNewsWire·3/23/2021·↑ positive

Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

PRNewsWire·2/11/2021·↑ positive